12-Sep-2023
The growing healthcare expenditure in Norway is driving up demand for the Norway Cone-Beam Computed Tomography (CBCT) Systems market during the forecast period.
Norway Cone-Beam Computed Tomography (CBCT) Systems Market was valued at USD 5.86 million in 2022, and is predicted to reach USD 16.3 million by 2030, with a CAGR of 12.72% from 2023 to 2030, according to new research by Next Move Strategy Consulting.
The escalating healthcare expenditure by the Norwegian government, with a focus on enhancing healthcare infrastructure and advancing disease detection and prevention, is poised to stimulate the growth of the CBCT market. For instance, as per data from the International Trade Administration, Norway ranks among the highest healthcare spenders globally, with the country's healthcare expenditure reaching USD 43 billion in 2021, equivalent to USD 7900 per resident. This heightened investment underscores Norway's dedication to improving healthcare services and facilitating precise diagnostic methods, ultimately fostering the expansion and uptake of advanced diagnostic tools such as CBCT.
However, the significant cost linked to the acquisition of Cone Beam Computed Tomography (CBCT) machines can act as a significant barrier to the growth of the CBCT market. The initial investment needed to acquire CBCT machines can be a deterrent, especially for healthcare facilities such as smaller clinics or practices with limited budgets. This elevated expense includes not just the purchase of the machine itself but also factors in costs associated with installation, maintenance, and training.
The financial challenges related to CBCT machines can impede their adoption, particularly in regions with limited resources or within healthcare environments where budget constraints are significant. This can lead to constraints on the availability and accessibility of CBCT technology, thereby hindering its widespread integration across various healthcare facilities.
On the other hand, the integration of Artificial Intelligence (AI) in CBCT software has the potential to revolutionize the field of imaging and significantly enhance the capabilities of CBCT technology. With AI algorithms, CBCT software can analyze and interpret images with greater precision and efficiency. These algorithms can be trained to automatically detect and segment anatomical structures, lesions, and abnormalities, providing valuable insights to clinicians. By automating these tasks, AI integration can save time and improve diagnostic accuracy, ultimately leading to more effective treatment planning.
Additionally, AI-powered CBCT software can simulate and visualize treatment outcomes, enabling clinicians to better plan and communicate treatment options with patients. Whether it's virtual implant placement, orthodontic treatment simulations, or surgical planning, the integration of AI in CBCT software offers new possibilities for personalized and optimized patient care. It holds the promise of streamlining workflows, reducing manual labor, and enhancing the overall efficiency and precision of CBCT imaging in various medical and dental applications.
According to the report, leading players in the Norway Cone-Beam Computed Tomography (CBCT) Systems market include Dentsply Sirona, Koninklijke Philips N.V., Vatech Co., Ltd, Envista Holdings, Planmeca OY, J. Morita Mfg. Corp., Cefla S.C., Hefei Meyer Optoelectronic Technology INC, Xoran Technologies LLC, Acteon Group, Hitachi Ltd., Genoray Co Ltd, Asahi RoEntgen Ind. Co. Ltd., OSSTEM IMPLANT CO., LTD., Largev Instrument Corp. Ltd., Carestream Dental LLC, Curvebeam AI, and HDXWILL.
The information related to key drivers, restraints, and opportunities and their impact on the Norway Cone-Beam Computed Tomography (CBCT) Systems market is provided in the report.
The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.
The market share of players in the Norway Cone-Beam Computed Tomography (CBCT) Systems market is provided in the report along with their competitive analysis.
The increased prevalence of non-communicable diseases is dri...
Increasing healthcare investment is driving the Uruguay in-v...
The increased prevalence of chronical diseases is driving th...
This website uses cookies to ensure you get the best experience on our website. Learn more
✖